BridgeMD
Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on postintubation Morbidity: A superiority cluster randomised controlled trial
EU CTIS ID: 2024-514913-37-00
What this study is testing
To estimate the effect of a combined strategy integrating rocuronium, bag face-mask ventilation before intubation and GEB e as an aid for tracheal intubation to the usual tracheal intubation process on early post-intubation related complications, in adult patients needing out-of hospital emergency tracheal intubation
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult (≥ 18 years) patient presenting with vital distress needing an emergency endotracheal intubation , and treated by the participating SMUR
- Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest
You likely can't join if
- Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist)
- Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis)
- Patient that are not members of a medical aid scheme (beneficiary or main member)
- Patient under specific protection measures: pregnant, parturient or nursing women ; legal protection or deprived of liberty : patient under judicial protection, patient under guardianship/curatorship
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.